CANNABINOID SCIENCE, BUILT FOR MEDICINE
Medical cannabis, held to pharma-grade standards.
IMCI formulations are built on NanoVATE Delivery™, our nano-emulsion platform, for higher bioavailability, faster onset and more consistent absorption than standard cannabis oil. We offer them to licensed partners in regulated medical cannabis markets.

WORK WITH IMCI
Who we work with.
NANOVATE DELIVERY™
Cannabinoids don’t mix with water. NanoVATE Delivery™ changes that.
Cannabinoids are fat-soluble, so standard cannabis oils are absorbed slowly and unevenly. NanoVATE Delivery™ forms nano-sized droplets on contact with water or body fluids, keeping cannabinoids dispersed and ready for absorption.

Self-Emulsifying
Droplets form spontaneously, with no special preparation.

Liquid and Solid Format
L-NanoVATE for liquids, S-NanoVATE for tablets, capsules and edibles.
HOW WE SUPPLY
One platform. Three market-ready routes.
Each market regulates medical cannabis differently. We formulate NanoVATE Delivery™ products for the supply route each market requires.

Final dosage form
Finished medical cannabis products, ready for dispensing, for supply under each market’s medical cannabis framework.
Israel / United Kingdom / Australia

Magistral
Formulations supplied to pharmacies that compound medical cannabis on prescription.
Germany / Switzerland

PreMix
A standardized cannabinoid ingredient for licensed manufacturers to use in their own products.
United States
SCIENCE AND RECOGNITION
Research with a path to market.
IMCI Pharmaceuticals is a pharmaceutical company developing cannabinoid formulations. Statements describe platform characteristics and are not medical claims for any specific product. Product availability, labeling and marketing are subject to each market’s regulations.









